You are on Trendlyne United States. Click here to go to India website or make United States as your default

Xylo Technologies Ltd. - ADR XNAS: XYLO

Xylo Technologies Ltd. - ADR Live Share Price Today, Share Analysis and Chart

4.91 -0.04 (-0.81%)

72.38% Fall from 52W High

29,486 XNAS Volume

XNAS 22 Apr, 2025 5:30 PM (EDT)

Board Meeting
The board meeting for Xylo Technologies Ltd. - ADR is scheduled for today, for the purpose of Xylo Technologies Ltd Fourth Quarter Earnings Results for 2024 See details
Not Eligible
-
Expensive Valuation
15.8 / 100
Technically Moderately Bullish
61.4 / 100

Xylo Technologies Ltd. - ADR Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '24Dec '25105110115Actual RevenueAvg. Estimate

Consensus Recommendation

1 ANALYST Recommendations
STRONG BUY

Created with Highcharts 7.2.21Strong Buy

The consensus recommendation from 1 analyst for Xylo Technologies Ltd. - ADR is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Xylo Technologies Ltd. - ADR Stock Analysis

Xylo Technologies Ltd. - ADR stock analysis with key metrics, changes, and trends.

Xylo Technologies Ltd. - ADR MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$91.72 M16.83%negative

Annual Revenue fell 16.83%, in the last year to $91.72 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit$16.02 M11.09%negative

Annual Net Profit fell 11.09% in the last year to $16.02 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Stock Price$4.91-29.76%negative

Stock Price fell 29.76% and underperformed its sector by 37.47% in the past year.

Debt to Equity Ratio0.42-positive

Debt to Equity Ratio of 0.42 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-51.10 %-51.1%negative

Return on Equity(ROE) for the last financial year was -51.1%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding0.00 %0%neutral

Mutual Fund Holding remained the same in the last quarter at 0%.

Interest Coverage Ratio-13.23-negative

Interest Coverage Ratio is -13.23, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding4.39 %0%negative

Institutional Holding decreased by 0% in the last quarter to 4.39.

VIEW LESS


Loading data..

Xylo Technologies Ltd. - ADR - Company Profile

What does Xylo Technologies Ltd. - ADR do?

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

Xylo Technologies Ltd. - ADR Management structure

All Gross Remunerations are in USD
Mr. Liron Carmel
Chief Executive Officer
451 K
2023
Gross Remuneration
Year
Ms. Tali Dinar
Chief Financial Officer
228 K
2023
Gross Remuneration
Year

Xylo Technologies Ltd. - ADR FAQ

How is Xylo Technologies Ltd. - ADR today?
Xylo Technologies Ltd. - ADR today is trading in the red, and is down by -0.81% at 4.91.
Xylo Technologies Ltd. - ADR is currently trading down -0.81% on an intraday basis. In the past week the stock fell -6.83%. stock has been up 9.11% in the past quarter and fell -29.76% in the past year. You can view this in the overview section.